Nordea Investment Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
ACM
Nordea Investment Management's CDLX Position: Q4 2020 in Review
Nordea Investment Management sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 7,537 shares — an estimated $5.42M sold.
Nordea Investment Management first reported a position in CDLX in Q2 2020 and held it in 2 quarters. The position peaked at $11.1M in Q2 2020. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.
- Nordea Investment Management reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
- Nordea Investment Management sold 7,537 Cardlytics shares in Q4 2020, an estimated $5.42M.
- Nordea Investment Management first reported a position in Cardlytics in Q2 2020 and held it in 2 quarters.
- Nordea Investment Management's Cardlytics position peaked at $11.1M in Q2 2020.
- 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.
Based on Nordea Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.